0001415889-24-012527.txt : 20240507
0001415889-24-012527.hdr.sgml : 20240507
20240507183044
ACCESSION NUMBER: 0001415889-24-012527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240503
FILED AS OF DATE: 20240507
DATE AS OF CHANGE: 20240507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alpern Robert J
CENTRAL INDEX KEY: 0001448074
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 24923640
MAIL ADDRESS:
STREET 1: YALE SCHOOL OF MEDICINE
STREET 2: 333 CEDAR STREET, C203 SHM
CITY: NEW HAVEN
STATE: CT
ZIP: 06520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
form4-05072024_060528.xml
X0508
4
2024-05-03
0001551152
AbbVie Inc.
ABBV
0001448074
Alpern Robert J
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
true
false
false
false
0
Common Stock, $0.01 par value
2024-05-03
4
A
0
1322
0
A
34443
D
These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
T.O. Odutayo, Attorney-in-Fact for Robert J. Alpern
2024-05-07